Abstract
D espite the overwhelming benefits that physician-industry collaboration and innovation have created over the last century, politicians, members of academia, and other public citizen groups have increasingly expressed their concern that physician-industry relationships may raise ethical issues, such as potential conflicts of interest. As a result of these concerns, Congress passed the Physician Payments Sunshine Act (“Sunshine Act”), section 6002 of the Affordable Care Act, in 2009. The Sunshine Act, now called Open Payments, does not directly change or prohibit relationships between manufacturer’s, physicians or teaching hospitals. Rather, the legislation and regulations require applicable pharmaceutical, biological and device manufacturers and group purchasing organizations (GPO), to report certain payments such entities make to physicians or teaching hospitals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
